147 related articles for article (PubMed ID: 31533941)
21. Inflammation and focal atrophy in prostate needle biopsy cores and association to prostatic adenocarcinoma.
Benedetti I; Bettin A; Reyes N
Ann Diagn Pathol; 2016 Oct; 24():55-61. PubMed ID: 27649956
[TBL] [Abstract][Full Text] [Related]
22. Postdiagnostic Statin Use and the Risk of Lethal Prostate Cancer in the Health Professionals Follow-up Study.
Chan JM; Kenfield SA; Paciorek A; Platz EA; Giovannucci EL; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1638-40. PubMed ID: 26189767
[TBL] [Abstract][Full Text] [Related]
23. Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer.
Dickerman BA; Ahearn TU; Giovannucci E; Stampfer MJ; Nguyen PL; Mucci LA; Wilson KM
Int J Cancer; 2017 Sep; 141(5):933-944. PubMed ID: 28543830
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of inflammation and prostate cancer.
Platz EA; De Marzo AM
J Urol; 2004 Feb; 171(2 Pt 2):S36-40. PubMed ID: 14713751
[TBL] [Abstract][Full Text] [Related]
25. Association between Trichomonas vaginalis and prostate cancer mortality.
Tsang SH; Peisch SF; Rowan B; Markt SC; Gonzalez-Feliciano AG; Sutcliffe S; Platz EA; Mucci LA; Ebot EM
Int J Cancer; 2019 May; 144(10):2377-2380. PubMed ID: 30242839
[TBL] [Abstract][Full Text] [Related]
26. Intratumoral Sterol-27-Hydroxylase (
Khan NA; Stopsack KH; Allott EH; Gerke T; Giovannucci EL; Mucci LA; Kantoff PW
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1052-1058. PubMed ID: 30867220
[TBL] [Abstract][Full Text] [Related]
27. Both acute and chronic inflammation are associated with less perineural invasion in men with prostate cancer on repeat biopsy.
Kuang AG; Nickel JC; Andriole GL; Castro-Santamaria R; Freedland SJ; Moreira DM
BJU Int; 2019 Jan; 123(1):91-97. PubMed ID: 29873889
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation.
Wang W; Bergh A; Damber JE
Prostate; 2007 Aug; 67(11):1238-46. PubMed ID: 17570496
[TBL] [Abstract][Full Text] [Related]
29. Prostate growth and inflammation.
Sciarra A; Mariotti G; Salciccia S; Autran Gomez A; Monti S; Toscano V; Di Silverio F
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):254-60. PubMed ID: 17935971
[TBL] [Abstract][Full Text] [Related]
30. Prostatic atrophy: an autopsy study of a histologic mimic of adenocarcinoma.
Billis A
Mod Pathol; 1998 Jan; 11(1):47-54. PubMed ID: 9556422
[TBL] [Abstract][Full Text] [Related]
31. A population-based study of progression to metastatic prostate cancer in Australia.
Luo Q; Yu XQ; Smith DP; O'Connell DL
Cancer Epidemiol; 2015 Aug; 39(4):617-22. PubMed ID: 25983117
[TBL] [Abstract][Full Text] [Related]
32. Hyperglycemia, Classified with Multiple Biomarkers Simultaneously in Men without Diabetes, and Risk of Fatal Prostate Cancer.
Marrone MT; Selvin E; Barber JR; Platz EA; Joshu CE
Cancer Prev Res (Phila); 2019 Feb; 12(2):103-112. PubMed ID: 30538098
[TBL] [Abstract][Full Text] [Related]
33. Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUC.
Gerke TA; Martin NE; Ding Z; Nuttall EJ; Stack EC; Giovannucci E; Lis RT; Stampfer MJ; Kantoff PW; Parmigiani G; Loda M; Mucci LA
Prostate; 2015 Dec; 75(16):1926-33. PubMed ID: 26469352
[TBL] [Abstract][Full Text] [Related]
34. Inflammation in prostate carcinogenesis.
De Marzo AM; Platz EA; Sutcliffe S; Xu J; Grönberg H; Drake CG; Nakai Y; Isaacs WB; Nelson WG
Nat Rev Cancer; 2007 Apr; 7(4):256-69. PubMed ID: 17384581
[TBL] [Abstract][Full Text] [Related]
35. Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.
Umbehr MH; Gurel B; Murtola TJ; Sutcliffe S; Peskoe SB; Tangen CM; Goodman PJ; Thompson IM; Lippman SM; Lucia MS; Parnes HL; Drake CG; Nelson WG; De Marzo AM; Platz EA
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):264-9. PubMed ID: 25939516
[TBL] [Abstract][Full Text] [Related]
36. Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy.
Hamid AA; Gray KP; Huang Y; Bowden M; Pomerantz M; Loda M; Sweeney CJ
Eur Urol Oncol; 2019 Sep; 2(5):475-482. PubMed ID: 31411988
[TBL] [Abstract][Full Text] [Related]
37. Tumor expression of adiponectin receptor 2 and lethal prostate cancer.
Rider JR; Fiorentino M; Kelly R; Gerke T; Jordahl K; Sinnott JA; Giovannucci EL; Loda M; Mucci LA; Finn S;
Carcinogenesis; 2015 Jun; 36(6):639-47. PubMed ID: 25863129
[TBL] [Abstract][Full Text] [Related]
38. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases.
Iczkowski KA; MacLennan GT; Bostwick DG
Am J Surg Pathol; 1997 Dec; 21(12):1489-95. PubMed ID: 9414193
[TBL] [Abstract][Full Text] [Related]
39. Baseline Prostate Atrophy is Associated with Reduced Risk of Prostate Cancer in Men Undergoing Repeat Prostate Biopsy.
Moreira DM; Bostwick DG; Andriole GL; Peterson BL; Cohen HJ; Castro-Santamaria R; Freedland SJ
J Urol; 2015 Nov; 194(5):1241-6. PubMed ID: 26165588
[TBL] [Abstract][Full Text] [Related]
40. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.
Wang W; Bergh A; Damber JE
Prostate; 2009 Sep; 69(13):1378-86. PubMed ID: 19507201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
